LITFULO ritlecitinib (as tosylate) 50 mg hard capsule bottle

Pfizer Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 2891c96ec803395b
Product Name: LITFULO ritlecitinib (as tosylate) 50 mg hard capsule bottle
Artg Id: 427294
Artg Name: LITFULO ritlecitinib (as tosylate) 50 mg hard capsule bottle
Sponsor: Pfizer Australia Pty Ltd
Company Detail Path: /organization/pfizer-australia-pty-ltd
Artg Date: 2024-07-09
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/fcf8d948441af628245649a7f9d5ad35.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/1878adb43f3e86d120c8632f0a1ee654.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

2891c96ec803395b

Type

Standard